Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2010 - 2026)
Integra Lifesciences Holdings recorded quarterly Asset Utilization Ratio of 0.46 in Q1 2026, up 1.53% quarter-over-quarter from 0.45 in Q4 2025, and up 14.08% year-over-year from 0.4 in Q1 2025.
Integra Lifesciences Holdings' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.46 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 14.08% year-over-year to 0.46; the TTM figure through Mar 2026 stood at 0.46 (up 14.08% YoY), while the FY2025 annual figure was 0.43, up 3.93% from the prior year.
- Asset Utilization Ratio came in at 0.46 for Q1 2026 at Integra Lifesciences Holdings, up from 0.45 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.46 in Q1 2026 to a low of 0.38 in Q2 2024.
- A 5-year average of 0.41 and a median of 0.41 in 2023 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio retreated 6.5% in 2024 and grew 16.84% in 2025, its largest moves.
- Integra Lifesciences Holdings' Asset Utilization Ratio stood at 0.4 in 2022, then climbed by 1.27% to 0.41 in 2023, then fell by 3.03% to 0.4 in 2024, then grew by 13.51% to 0.45 in 2025, then climbed by 1.53% to 0.46 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.46, 0.45, and 0.45 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.56 |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.46 |
| Dec 31, 2025 | 0.45 |
| Sep 30, 2025 | 0.45 |
| Jun 30, 2025 | 0.42 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.38 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.41 |
| Sep 30, 2023 | 0.41 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.41 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | 0.41 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.40 |
| Mar 31, 2021 | 0.37 |
| Dec 31, 2020 | 0.39 |
| Sep 30, 2020 | 0.40 |
| Jun 30, 2020 | 0.41 |
| Mar 31, 2020 | 0.45 |
| Dec 31, 2019 | 0.46 |
| Sep 30, 2019 | 0.45 |
| Jun 30, 2019 | 0.46 |
| Mar 31, 2019 | 0.47 |
| Dec 31, 2018 | 0.47 |
| Sep 30, 2018 | 0.46 |
| Jun 30, 2018 | 0.43 |
| Mar 31, 2018 | 0.40 |
| Dec 31, 2017 | 0.42 |
| Sep 30, 2017 | 0.48 |
| Jun 30, 2017 | 0.50 |
| Mar 31, 2017 | 0.53 |
| Dec 31, 2016 | 0.55 |
| Sep 30, 2016 | 0.54 |
| Jun 30, 2016 | 0.52 |
| Mar 31, 2016 | 0.51 |
| Dec 31, 2015 | 0.49 |
| Sep 30, 2015 | 0.50 |
| Jun 30, 2015 | 0.52 |
| Mar 31, 2015 | 0.52 |
| Dec 31, 2014 | 0.51 |
| Sep 30, 2014 | 0.51 |
| Jun 30, 2014 | 0.52 |
| Mar 31, 2014 | 0.60 |
| Dec 31, 2013 | 0.70 |
| Sep 30, 2013 | 0.70 |
| Jun 30, 2013 | 0.71 |
| Mar 31, 2013 | 0.72 |
| Dec 31, 2012 | 0.71 |
| Sep 30, 2012 | 0.70 |
| Jun 30, 2012 | 0.70 |
| Mar 31, 2012 | 0.69 |
| Dec 31, 2011 | 0.67 |
| Sep 30, 2011 | 0.66 |
| Jun 30, 2011 | 0.70 |
| Mar 31, 2011 | 0.73 |
| Dec 31, 2010 | 0.74 |
| Sep 30, 2010 | 0.76 |